Engineered pluripotent stem cell-derived cardiomyocytes prevent serious engraftment-related arrhythmia in nonhuman primates

Back

ESC2025 Premium Access

Engineered pluripotent stem cell-derived cardiomyocytes prevent serious engraftment-related arrhythmia in nonhuman primates

Session: Molecular and cellular drivers of arrhythmia

Topic: Gene Therapy, Cell Therapy

Speaker: Associate Professor K. Nakamura (Seattle, US)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Associate Professor Kenta Nakamura

University of Washington, Seattle (United States of America)

0 follower

4 more presentations in this session

Investigation of a novel SLC4A3 variant causing short QT Syndrome: functional and pharmacological evaluation in a knock-in zebrafish model

Speaker: Ms M. Zhu (Suita, JP)

SGK1 inhibition shortens action potential duration and exerts anti-arrhythmic effects in LQT3 mice and LQT2 rabbits by reducing enhanced late sodium current

Speaker: Doctor S. Casini (Amsterdam, NL)

DECA11 selectively increases human INa and IK1 and is antiarrhythmic in a mouse model of heart failure

Speaker: Professor R. Caballero (Madrid, ES)

Atrial electrophysiological disturbances caused by disruption of the RBM20 splicing factor

Speaker: Mr L. Weirauch (Heidelberg, DE)

Access the full session

Molecular and cellular drivers of arrhythmia

Speakers: Associate Professor K. Nakamura, Ms M. Zhu, Doctor S. Casini, Professor R. Caballero, Mr L. Weirauch

Access

Video

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources